Glen Campbell's sad case shows again why AVXL's drug is needed so desperately -- even if all it does is slow the rate of decline (although we're hoping for results similar to what the preliminary results were, indicating cognitive improvement).

http://www.ijreview.com/2015/10/457903-glen-c...newsletter